Trial Profile
A monocentric Phase IIa trial of bumetanide.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Mar 2017
Price :
$35
*
At a glance
- Drugs Bumetanide (Primary)
- Indications Autistic disorder; Pervasive child development disorders
- Focus Therapeutic Use
- 23 Mar 2017 New trial record